CRISPR/Cas9-mediated knockout of inositol-pentakisphosphate 2-kinase (IPPK), which is an enzyme involved in the biosynthesis of IP6, led to more than a 10-fold decrease in HIV-1 infections [20]. Here, IPPK is linked to HIV-1 infection.